Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
Japanese Market for Interventional Cardiology 2010
US$ 7,495.00
... Japan has one of the oldest populations in the world, and demographic pressure is increasing the demand for healthcare. As a result, the Japanese ... increasing utilization of IVUS and OCT. Within the Japanese interventional cardiology device market, companies such as Abbott Laboratories, Asahi Intecc, Boston ...
March 2010
231 pages
Infectious Disease Molecular Diagnostic Testing
US$ 2,000.00
Global PDF: US$ 5,500.00 The report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products. Contains 360 pages and 20 tables
February 2010
360 pages
Growth Opportunities for LVAD in Heart Failure Market
US$ 750.00
... indication established by the FDA, would also open new growth avenues for LVADs. The report provides an overview of the heart failure and ... the associated end stage heart failure cost and LVAD reimbursement. The growth drivers and challenges are also discussed. The key ...
February 2010
36 pages
Chronic Obstructive Pulmonary Disease: Market Research Report
US$ 3,450.00
This report analyzes the worldwide markets for Chronic Obstructive Pulmonary Disease in US$ Million. The report provides separate comprehensive analytics for US and ... SICAR, Schering-Plough Corporation, Sepracor, Inc., and Vectura Group plc. Market data and analytics are derived from primary and secondary ...
February 2010
432 pages
Cancer Bladder Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Bladder Cancer Therapy Area Pipeline Report contains detailed information on the bladder cancer drug pipeline. This report provides insight into the pipeline status of bladder...
January 2010
138 pages
Cancer Brain Tumor Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Brain Tumor Therapy Area Pipeline Report contains detailed information on the brain tumor drug pipeline. This report provides insight into the pipeline status of brain tumor d...
January 2010
373 pages
Cancer Breast Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Breast Cancer Therapy Area Pipeline Report contains detailed information on the breast cancer drug pipeline. This report provides insight into the pipeline status of breast ca...
January 2010
1119 pages
Cancer Head and Neck Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Head and Neck Cancer Therapy Area Pipeline Report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline statu...
January 2010
406 pages
Cancer Kidney Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Kidney Cancer Therapy Area Pipeline Report contains detailed information on the kidney cancer drug pipeline. This report provides insight into the pipeline status of kidney ca...
January 2010
391 pages
Cancer Liver Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Liver Cancer Therapy Area Pipeline Report contains detailed information on the liver cancer drug pipeline. This report provides insight into the pipeline status of liver cance...
January 2010
401 pages
Cancer Lymphoma Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Lymphoma Therapy Area Pipeline Report contains detailed information on the lymphoma drug pipeline. This report provides insight into the pipeline status of lymphoma drugs by c...
January 2010
229 pages
Cancer Melanoma or Skin Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Melanoma or Skin Cancer Therapy Area Pipeline Report contains detailed information on the melanoma or skin cancer drug pipeline. This report provides insight into the pipeline...
January 2010
514 pages
Cancer Multiple Myeloma Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Multiple Myeloma Therapy Area Pipeline Report contains detailed information on the multiple myeloma drug pipeline. This report provides insight into the pipeline status of mul...
January 2010
691 pages
Cancer Non-Hodgkin Lymphoma Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Non-Hodgkin Lymphoma Therapy Area Pipeline Report contains detailed information on the non-hodgkin lymphoma drug pipeline. This report provides insight into the pipeline statu...
January 2010
701 pages
Cancer Ovarian Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Ovarian Cancer Therapy Area Pipeline Report contains detailed information on the ovarian cancer drug pipeline. This report provides insight into the pipeline status of ovarian...
January 2010
500 pages
Cancer Pancreatic Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Pancreatic Cancer Therapy Area Pipeline Report contains detailed information on the pancreatic cancer drug pipeline. This report provides insight into the pipeline status of p...
January 2010
426 pages
Cancer Prostate Cancer Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Prostate Cancer Therapy Area Pipeline Report contains detailed information on the prostate cancer drug pipeline. This report provides insight into the pipeline status of prost...
January 2010
770 pages
Infections Hepatitis B Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Hepatitis B Therapy Area Pipeline Report contains detailed information on the hepatitis b drug pipeline. This report provides insight into the pipeline status of hepatitis b d...
January 2010
332 pages
Infections Hepatitis C Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Hepatitis C Therapy Area Pipeline Report contains detailed information on the hepatitis c drug pipeline. This report provides insight into the pipeline status of hepatitis c d...
January 2010
888 pages
Infections Hepatitis Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Hepatitis Therapy Area Pipeline Report contains detailed information on the hepatitis drug pipeline. This report provides insight into the pipeline status of hepatitis drugs b...
January 2010
65 pages
Breast Cancer Market– An Analysis
US$ 800.00
... US and Europe. Breast cancer market is comprised of two segments - diagnostic and therapy. The key drivers of breast cancer market are aging population, ... therapy or both are used. The major players of breast cancer market are strengthening their networks through international alliances, agreements, strategic ...
January 2010
39 pages
European Markets for Interventional Cardiology 2009 (15 Countries)
US$ 11,495.00
... 2008, the European market for interventional cardiology was valued at over €1.5 billion. The interventional cardiology market includes drug-eluting stents, ... devices, and IVUS catheters. In addition, this report covers the emerging markets for optical coherence tomography (OCT), vulnerable plaque screening, PFO ...
October 2009
409 pages
Infectious Disease Diagnostic Markets
US$ 3,500.00
The ubiquity of infections makes thier detection a healthcare priority and an ongoing opportunity for IVD companies. The aging of the population, and emerging threats - MRSA, swine flu, and others hav...
August 2009
180 pages